T hroughout history, infectious disease has been a major cause of death and disability. Each day, one third of the world's deaths are related to infection. In the United States, the antibiotic era beginning in the 1950s radically reduced morbidity and mortality from infectious disease. Coupled with advances in public health and sanitation practices, the average life expectancy increased from 47 in 1900 to 75 years. 1 However, antimicrobial resistance has been an ongoing problem during the past 50 years. 2 When penicillin was introduced in the 1940s, resistant strains of microbes were manifest in hospitals by 1946. This is also the case today. Introduction of new antimicrobials is usually followed by rapid emergence of resistant strains that once were initially susceptible. 3 
ANTIMICROBIAL RESISTANCE
Antimicrobial resistance is a complex expression of the interplay of the genetic characteristics of the microbe and drug activity, and occurs when drug therapy does not kill the bacteria causing the infection. Bacteria survive and continue to multiply. [2] [3] [4] Normally, antimicrobials demonstrate selective toxicity at specific sites of bacterial structure or function: the bacterial cell wall, protein and folic acid synthesis, nucleic acid metabolism or the cell mem- brane. Resistance usually develops through 1 of 5 pathways: production of drug-inactivating enzymes, modification of the existing target, acquisition of a target bypass system, reduced cell permeability, or drug removal from the cell. 3 Intrinsic or natural resistance results in a gradual increase in the minimal inhibitory concentration for susceptible organisms over time. As a result, a greater amount of antimicrobial agent is needed to kill the organism. When a previously sensitive organism is suddenly no longer sensitive at any dose of antimicrobial, resistance is described as acquired or absolute resistance. 2, 3 Resistance to antimicrobials does not always occur following widespread use since resistance is a function of the antimicrobial and organism combination. 3, 4 Bacteria will continue to evolve and acquire new mechanisms of resistance. 2 However, there are many other factors that powerfully influence the development of drug-resistant organisms.
FACTORS PROMOTING RESISTANCE
Patients play a significant role in the emergence, spread, and control of bacterial resistance. 5 Despite the widespread information that antibiotics are not effective in viral infections, the pressure to prescribe antibiotics continues. Despite warning labels and instructions, many patients, once feeling better, do not complete the entire prescription and remaining bacteria survive to become resistant strains. Patients continue to share remaining doses with others. Broad-spectrum complementary drug samples coupled with generally inadequate insurance coverage for narrowspectrum antibiotics also encourage inappropriate prescribing. Finally, the availability of over-the-counter antibiotics outside the United States promotes the development of powerful resistant strains worldwide. All of these factors have significantly contributed to the emergence of increasingly resistant organisms. 2, 5, 6 The use of antimicrobials in farming and agriculture is also a major problem. Antimicrobials are often used in farming to prevent illnesses caused by poor feeding, over-crowding, and disease-promoting environments. While antimicrobials encourage growth and profit, the risk to society is the further development of resistant organisms. More humane treatment of animals would solve many of the problems being currently managed by antimicrobials. 2, 4, 6 Widespread use of aerially sprayed antibiotics to prevent and treat cosmetic plant disease, resulting in drifts of sublethal doses of antimicrobial to populations worldwide, also induces resistance. 6 Healthcare shares responsibility for the development of resistant strains. Inappropriate prescribing, failure to test for sensitivity, insufficient handwashing, poor infection control practices, and prophylactic use of antimicrobials rather than improved hygiene and sterility measures are just a few of the problems. While the current focus has been to reduce the use of antimicrobials to reduce the risk of colonization and development of resistant strains, antibiotic control does not always result in reduction of the prevalence of resistance. 2, 4 The home has been suggested as a contributing factor in the rise of resistant strains. The too-clean environment hypothesis suggests that excessively clean environments and limited contact with microbes have contributed to the development of weak immune systems, which has increased the risk of developing severe as well as resistant infections. At this time, evidence does not support that antimicrobial detergents and disinfectants have contributed to the development of resistant strains. Other contributing factors for drug resistance currently being explored include genetics, smoking, pollution, diet, and lack of exercise. 7 In summary, modern life has changed the way humans interact with microbes and will continue to do so. A local infection can become a worldwide concern in a matter of hours with air travel. Behavior and professional practices as well as the environment influence the antimicrobialorganism relationship and subsequent outcomes.
IMPLICATIONS FOR THE CLINICAL NURSE SPECIALIST
Antibiotic resistance will continue to be a major problem into the 21st century. 2 Unless preventative strategies combined with drug development occur, it may become common rather than rare to manage patients with highly resistant organisms for which no effective antibiotics are available. 1 Early and appropriate therapy can limit the spread of multi-resistant infections. Knowledge of local resistance patterns is the basis of providing the best empirical therapy. Ideally, inpatient unit data should be analyzed separately to discern patterns of resistance, because patterns within the same hospital can vary widely. 2 Individual surveillance of units is more expensive but valuable in provision of accurate information for prescribing.
Poor infection control is usually related to lack of resources (people or money), apathy, and ignorance. Since infections have major financial implications related to increased length of stay and litigation, continuous education and surveillance are necessary. Sensible infection control measures include isolating patients with multi-resistant organisms or cohorting patients with the same organisms.
Washing and completely drying hands between patients sounds simple, yet handwashing standards are difficult to achieve in high-acuity environments with limited staffing. 2 The CNS can positively influence practice by being a model and mentor of good infection control practices.
There are a variety of processes currently used by hospitals worldwide to decrease the development of resistant organisms. Formulary restrictions, prior approval mechanisms, preprinted order forms, stop orders, antimicrobial management teams, and antibiotic rotation are just a few of the interventions being used. Whether these interventions have decreased the development of resistant organisms is still unknown. Current evidence is very limited and more research is needed to determine best practice in prescribing antimicrobials. 4, 8 The elderly are of particular concern. The aged have a greater risk of dying from an infection and suffering serious complications related to low cell-mediated immunity and the presence of chronic conditions, which increase the vulnerability to infection. Detection of infection in the elderly, particularly the very old, is more difficult because the fever response is blunted in 20% to 30% of elders with serious infections. Rather than fever, signs and symptoms of infection in the aged may include cognitive impairment, decline in functioning, falls, weight loss, and weakness. This atypical presentation often delays diagnosis and treatment. 1 
THE FUTURE
In the future, susceptibility testing may be expressed more accurately. Rather than the simple labels of S (susceptible), I (intermediate), and R (resistant), direct detection of the gene responsible for the mechanism of resistance will be identified. 4 This may improve prescribing practices and subsequent outcomes.
Some plants appear to have the potential ability to diminish antibiotic resistance. Early evidence suggests that tea (green and black), garlic, mushrooms, and milk thistle are effective in assisting antimicrobials to overcome resistance and boosting immune responses. 9 Certainly, more research is needed.
Finally, a new phenomenon since September 11, 2001 is the stockpiling and consuming of antimicrobial agents for the treatment or prevention of a potential epidemic. The outcomes related to this process are unknown. The recent anthrax scare resulted in increased sales of ciprofloxacin, and thousands received prophylaxis for confirmed and suspected exposures. Public health concerns about massive consumption of antimicrobial drugs leading to further development of powerful resistant strains are valid. For many reasons, clinicians should strongly discourage the home stockpiling of antibiotics. 10 
SUMMARY
This article has explored the complex factors associated with development of resistant organisms. There is no one cause for the development of resistant microbes. However, the CNS can powerfully impact many of the factors contributing to the development of resistance. Education of patients, modeling and mentoring infection control practices, appropriate prescribing, and keeping current with up-to-date guidelines from the Centers for Disease Control and Prevention (CDC) are a good beginning. CDC guidelines and recommendations can be obtained at www.cdc.gov.
